Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1312
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01121718 | NIR-Guided Sentinel Lymph Node Mapping in Melanoma | ||
| NCT07232043 | ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs | ||
| NCT01494662 | HKI-272 for HER2-Positive Breast Cancer and Brain Metastases | ||
| NCT01788631 | A Phase II Trial of Regadenoson in Sickle Cell Anemia | ||
| NCT05375643 | SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention) | ||
| NCT02123966 | An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease | ||
| NCT03426878 | Cancer Health Assessments Reaching Many | ||
| NCT02450708 | Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes | ||
| NCT02041325 | Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias | ||
| NCT00953446 | Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell Carcinoma | ||
| NCT04024761 | A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation | ||
| NCT04724018 | Sacituzumab Govitecan Plus EV in Metastatic UC | ||
| NCT01191697 | CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer | ||
| NCT05701488 | SIRT With Tremelimumab and Durvalumab for Resectable HCC | ||
| NCT02903368 | Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy | ||
| NCT01834183 | Tivozanib + Gemcitabine in Metastatic RCC | ||
| NCT01273805 | Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer | ||
| NCT01965353 | A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma | ||
| NCT02582697 | Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours | ||
| NCT00483223 | Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response | ||
| NCT01853345 | iCAT for Recurrent/Refractory/HR Solid Tumors | ||
| NCT00006123 | Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer | ||
| NCT00142480 | Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer | ||
| NCT04997096 | Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy | ||
| NCT02172651 | Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases | ||
| NCT02919670 | A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma | ||
| NCT03310879 | Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6 | ||
| NCT01112527 | PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma | ||
| NCT00136396 | Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease | ||
| NCT04541654 | Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress | ||
| NCT00657267 | Dose-Intense Temozolomide in Recurrent Glioblastoma | ||
| NCT02865811 | Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer | ||
| NCT03291730 | A Nurse Led Project to Introduce Hand Lettering as a Form of Creative Art Expression to Patients in an Ambulatory Oncology Setting | ||
| NCT02478164 | Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma | ||
| NCT04732065 | ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors | ||
| NCT02604511 | Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing | ||
| NCT04893109 | ATEMPT 2.0: Adjuvant T-DM1 vs TH | ||
| NCT00004081 | Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer | ||
| NCT01786811 | Serious Illness Communication Project | ||
| NCT01239381 | Individualized Stereotactic Body Radiotherapy of Liver Metastases | ||
| NCT01665937 | STA-9090 in Patients With Advanced Hepatocellular Cancer | ||
| NCT07714551 | Zanzalintinib in Unresectable and Progressive MPGGs | ||
| NCT00144677 | Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation | ||
| NCT00264602 | Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer | ||
| NCT00869999 | Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma | ||
| NCT00165295 | Sildenafil Citrate in Waldenstrom's Macroglobulinemia | ||
| NCT01954979 | Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD) | ||
| NCT04201145 | Pembrolizumab + Defactinib In Pleural Mesothelioma | ||
| NCT00146614 | Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation | ||
| NCT06152809 | CIML NK Cells With Venetoclax for AML |
